Found: 15
Select item for more details and to access through your institution.
Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2671, doi. 10.3390/cancers16152671
- By:
- Publication type:
- Article
Clinical impact of using [<sup>18</sup>F]AlF‐NOTA‐octreotide PET/CT instead of [<sup>68</sup>Ga]Ga‐DOTA‐SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 8, p. 1, doi. 10.1111/jne.13420
- By:
- Publication type:
- Article
Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00480-y
- By:
- Publication type:
- Article
The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 12, p. 1833, doi. 10.1007/s11864-023-01147-3
- By:
- Publication type:
- Article
Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11327-x
- By:
- Publication type:
- Article
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 8, p. 965, doi. 10.1007/s11864-023-01095-y
- By:
- Publication type:
- Article
The Role of Immunotherapy in Esophageal and Gastric Cancer.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 175, doi. 10.1016/j.clcc.2023.03.001
- By:
- Publication type:
- Article
Prospective comparison of [<sup>18</sup>F]AlF-NOTA-octreotide PET/MRI to [<sup>68</sup>Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-01003-3
- By:
- Publication type:
- Article
<sup>18</sup>F-AlF-NOTA-Octreotide Outperforms <sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 632, doi. 10.2967/jnumed.122.264563
- By:
- Publication type:
- Article
<sup>18</sup>F-AlF-NOTA-octreotide outperforms <sup>68</sup>Ga-DOTA-TATE/-NOC PET in neuroendocrine tumor patients: results from a prospective, multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264563
- By:
- Publication type:
- Article
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 987, doi. 10.3390/cancers13050987
- By:
- Publication type:
- Article
PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1461, doi. 10.3390/cancers12061461
- By:
- Publication type:
- Article
Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2019, v. 20, n. 3, p. 333, doi. 10.1007/s11154-019-09508-w
- By:
- Publication type:
- Article
Cell-Free DNA From Metastatic Pancreatic Neuroendocrine Tumor Patients Contains Tumor-Specific Mutations and Copy Number Variations.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00467
- By:
- Publication type:
- Article
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors.
- Published in:
- 2016
- By:
- Publication type:
- journal article